About

Ken-ichiro Kuninobu, MSc, RPh

Co-founder and representative director

CEO

15years+ experience in the pharmaceutical industry. He led the US regulatory and clinical affairs of the department of regenerative medicines in NIPRO until 2022 in collaboration with Yale University

Ken-ichi Yamada, Ph.D.

Co-founder and board of director

CSO

Professor of Kyushu University. Dr.Yamada is the Principal investigator of basic research on elucidation of disease mechanisms and drug discovery by targeting oxidized lipids. He worked as a research fellow in NIH(NIH/NCI:Dr. Murali C. Krishna)

Samir Tari, M.D., MBA

Consultant Medical Director

Dr.Tari has 16 years+ experience in the pharmaceutical executive in ophthalmology space. He served as Senior Director of Medical Affairs at Regeneron, Global Medical Lead and Senior Medical Director at Astellas.


Name:FELIQS CORPORATION

Address1-1 Hyakunenkoen, Kurume, Fukuoka, 8390864, JAPAN 

Capital:50,000,000 JPY

Main bank:MUFG bank